ClinicalTrials.gov
ClinicalTrials.gov Menu

Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting Conditions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00959933
Recruitment Status : Completed
First Posted : August 17, 2009
Last Update Posted : March 28, 2017
Sponsor:
Information provided by:
Sandoz

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2001
  Actual Study Completion Date : May 2001